Meeting Details
- Board meeting scheduled for Monday, July 20, 2026
- Submitted by Birendra Kumar Jain, Company Secretary & Compliance Officer (M No. F13320)
- Submission date: July 3, 2026 at 12:01:16 +05'30'
Agenda Items
1. Consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
2. Consider and recommend 1st Interim dividend, if any, for financial year 2026-27
3. Discuss proposal for raising funds in one or more tranches through:
- Equity shares
- Fully or partly convertible debentures
- Convertible preference shares
- Warrants (detachable or otherwise)
- Any other instruments convertible into or linked to equity shares
- Non-convertible debentures
Fundraising Methods Considered
Through permissible modes including public issue(s), rights issue(s), preferential allotment(s), private placement(s), qualified institutions placement(s) or any combination thereof, or any other method as permitted under applicable laws.
Regulatory Framework
Subject to provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and subject to statutory and regulatory approvals including shareholders' approval as required.
Trading Window Closure
- Trading Window closed from Wednesday, July 1, 2026
- Will remain closed until 48 hours after declaration of financial results
- Closure implemented pursuant to Company's Code of Conduct for Prevention of Insider Trading